Ironwood Pharmaceuticals (IRWD) EBITDA Margin Growth (1y) (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 1,699.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,699.00 |
| Mar 31, 2026 | 13,889.00 |
| Dec 31, 2025 | -2,052.00 |
| Sep 30, 2025 | 3,385.00 |
| Jun 30, 2025 | 2,671.00 |
| Mar 31, 2025 | -8,547.00 |
| Dec 31, 2024 | 280.00 |
| Sep 30, 2024 | -720.00 |
| Jun 30, 2024 | 103,514.00 |
| Mar 31, 2024 | -4,303.00 |
| Dec 31, 2023 | -3,180.00 |
| Sep 30, 2023 | -2,784.00 |
| Jun 30, 2023 | -106,592.00 |
| Mar 31, 2023 | -156.00 |
| Dec 31, 2022 | 1,546.00 |
| Sep 30, 2022 | 21.00 |
| Jun 30, 2022 | -534.00 |
| Mar 31, 2022 | 821.00 |
| Dec 31, 2021 | 428.00 |
| Sep 30, 2021 | 1,873.00 |